Among the death receptor ligands, APO2L/TRAIL has been shown to induce apoptosis in a variety of transformed cells while sparing normal cells, and constitutive expression of TRAIL receptors has been observed in a variety of tumor types. This evidence concerns the gene TNFSF10 and neoplasm.